Decision Aid Summary
|Title||Starting Immune Tolerance Induction (to get rid of inhibitors): when and what dose.|
|Audience||Persons with hemophilia A or B who have developed an inhibitor to factor concentrate. Clinician and patient versions.|
|Options included||Delayed start of Immune Tolerance Induction (ITI)
Early start of ITI.
High dose ITI with Immunosuppresant.
High dose ITI.
Low dose ITI.
|Year of last update or review||2013|
|Format||Web, paper, PDF|
|How to obtain||Click here to view the decision aid on the developer website|
|Where was it firstname.lastname@example.org
McMaster University and Université Laval
|Type of decision aid||Treatment|
|Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:|
|6 out of 7 criteria to be defined as a patient decision aid|
|7 out of 8 criteria to lower the risk of making a biased decision|
|Not applicable: other criteria for decision aids about screening or testing|
Last modified: 2017-04-06.